Literature DB >> 19841077

Absence of inflammation and pneumonia during infection with nonpigmented Yersinia pestis reveals a new role for the pgm locus in pathogenesis.

Hanni Lee-Lewis1, Deborah M Anderson.   

Abstract

Yersinia pestis causes primary pneumonic plague in many mammalian species, including humans, mice, and rats. Virulent Y. pestis strains undergo frequent spontaneous deletion of a 102-kb chromosomal DNA fragment, known as the pigmentation (pgm) locus, when grown in laboratory media, yet this locus is present in every virulent isolate. The pgm locus encodes, within a high-pathogenicity island, siderophore biosynthesis genes that are required for growth in the mammalian host when inoculated by peripheral routes. Recently, higher challenge doses of nonpigmented Y. pestis were reported to cause fatal pneumonic plague in mice, suggesting a useful model for studies of virulence and immunity. In this work, we show that intranasal infection of BALB/c mice with nonpigmented Yersinia pestis does not result in pneumonic plague. Despite persistent bacterial colonization of the lungs and the eventual death of infected mice, pulmonary inflammation was generally absent, and there was no disease pathology characteristic of pneumonic plague. Iron given to mice at the time of challenge, previously shown to enhance the virulence of pgm-deficient strains, resulted in an accelerated disease course, with less time to bacteremia and lethality, but lung inflammation and pneumonia were still absent. We examined other rodent models and found differences in lung inflammatory responses, some of which led to clearance and survival even when high challenge doses were used. Together, the results suggest that the Y. pestis pgm locus encodes previously unappreciated virulence factors required for the induction of pneumonic plague that are independent of iron scavenging from the mammalian host.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19841077      PMCID: PMC2798233          DOI: 10.1128/IAI.00559-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Yersinia pestis TonB: role in iron, heme, and hemoprotein utilization.

Authors:  Robert D Perry; Jessica Shah; Scott W Bearden; Jan M Thompson; Jacqueline D Fetherston
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

2.  Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV.

Authors:  Kristin L DeBord; Deborah M Anderson; Melanie M Marketon; Katie A Overheim; R William DePaolo; Nancy A Ciletti; Bana Jabri; Olaf Schneewind
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

3.  A plasminogen-activating protease specifically controls the development of primary pneumonic plague.

Authors:  Wyndham W Lathem; Paul A Price; Virginia L Miller; William E Goldman
Journal:  Science       Date:  2007-01-26       Impact factor: 47.728

4.  LcrV plague vaccine with altered immunomodulatory properties.

Authors:  Katie A Overheim; R William Depaolo; Kristin L Debord; Elizabeth M Morrin; Debra M Anderson; Nathaniel M Green; Robert R Brubaker; Bana Jabri; Olaf Schneewind
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops).

Authors:  K J Davis; D L Fritz; M L Pitt; S L Welkos; P L Worsham; A M Friedlander
Journal:  Arch Pathol Lab Med       Date:  1996-02       Impact factor: 5.534

6.  Prevalence of the "high-pathogenicity island" of Yersinia species among Escherichia coli strains that are pathogenic to humans.

Authors:  S Schubert; A Rakin; H Karch; E Carniel; J Heesemann
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

7.  Hierarchy of iron uptake systems: Yfu and Yiu are functional in Yersinia pestis.

Authors:  Olga Kirillina; Alexander G Bobrov; Jacqueline D Fetherston; Robert D Perry
Journal:  Infect Immun       Date:  2006-09-05       Impact factor: 3.441

8.  Chromosomal irp2 gene in Yersinia: distribution, expression, deletion and impact on virulence.

Authors:  A M de Almeida; A Guiyoule; I Guilvout; I Iteman; G Baranton; E Carniel
Journal:  Microb Pathog       Date:  1993-01       Impact factor: 3.738

9.  Transmission of Yersinia pestis from an infectious biofilm in the flea vector.

Authors:  Clayton O Jarrett; Eszter Deak; Karen E Isherwood; Petra C Oyston; Elizabeth R Fischer; Adeline R Whitney; Scott D Kobayashi; Frank R DeLeo; B Joseph Hinnebusch
Journal:  J Infect Dis       Date:  2004-07-12       Impact factor: 5.226

10.  Cytokine-mediated activation of macrophages from Mycobacterium bovis BCG-resistant and -susceptible mice: differential effects of corticosterone on antimycobacterial activity and expression of the Bcg gene (Candidate Nramp).

Authors:  D H Brown; W LaFuse; B S Zwilling
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

View more
  23 in total

Review 1.  Yersiniabactin iron uptake: mechanisms and role in Yersinia pestis pathogenesis.

Authors:  Robert D Perry; Jacqueline D Fetherston
Journal:  Microbes Infect       Date:  2011-05-12       Impact factor: 2.700

2.  Resistance of Mice of the 129 Background to Yersinia pestis Maps to Multiple Loci on Chromosome 1.

Authors:  Michael Tencati; Richard I Tapping
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

Review 3.  The role of transition metal transporters for iron, zinc, manganese, and copper in the pathogenesis of Yersinia pestis.

Authors:  Robert D Perry; Alexander G Bobrov; Jacqueline D Fetherston
Journal:  Metallomics       Date:  2015-06       Impact factor: 4.526

4.  Intranasal prophylaxis with CpG oligodeoxynucleotide can protect against Yersinia pestis infection.

Authors:  Anthony J Hickey; Jr-Shiuan Lin; Lawrence W Kummer; Frank M Szaba; Debra K Duso; Michael Tighe; Michelle A Parent; Stephen T Smiley
Journal:  Infect Immun       Date:  2013-04-01       Impact factor: 3.441

5.  Chemokine receptor CXCR2 mediates bacterial clearance rather than neutrophil recruitment in a murine model of pneumonic plague.

Authors:  Nicholas A Eisele; Hanni Lee-Lewis; Cynthia Besch-Williford; Charles R Brown; Deborah M Anderson
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

6.  TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.

Authors:  Jr-Shiuan Lin; Steven Park; Jeffrey J Adamovicz; Jim Hill; James B Bliska; Christopher K Cote; David S Perlin; Kei Amemiya; Stephen T Smiley
Journal:  Vaccine       Date:  2010-09-15       Impact factor: 3.641

7.  A live attenuated strain of Yersinia pestis KIM as a vaccine against plague.

Authors:  Wei Sun; David Six; Xiaoying Kuang; Kenneth L Roland; Christian R H Raetz; Roy Curtiss
Journal:  Vaccine       Date:  2011-02-12       Impact factor: 3.641

8.  Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa.

Authors:  Estela M Galván; Manoj Kumar Mohan Nair; Huaiqing Chen; Fabio Del Piero; Dieter M Schifferli
Journal:  Infect Immun       Date:  2010-05-24       Impact factor: 3.441

9.  Modification of the Pulmonary MyD88 Inflammatory Response Underlies the Role of the Yersinia pestis Pigmentation Locus in Primary Pneumonic Plague.

Authors:  Rachel M Olson; Miqdad O Dhariwala; William J Mitchell; Jerod A Skyberg; Deborah M Anderson
Journal:  Infect Immun       Date:  2021-02-16       Impact factor: 3.441

10.  Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaques.

Authors:  Qingwen Zhang; Qiong Wang; Guang Tian; Zhizhen Qi; Xuecan Zhang; Xiaohong Wu; Yefeng Qiu; Yujing Bi; Xiaoyan Yang; Youquan Xin; Jian He; Jiyuan Zhou; Lin Zeng; Ruifu Yang; Xiaoyi Wang
Journal:  Hum Vaccin Immunother       Date:  2013-11-13       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.